Intersint is a small Norwegian R&D company working to gain more insight into cellular and molecular mechanisms involved in development of brain cancer glioblastoma and neurodegenerative diseases such as Alzheimer´s disease, Parkinson´s disease and multiple sclerosis. New insight is used in drug discovery and drug development.